a

3S Corporation is one of India’s leading stockist, exporter & wholesaler for Anti-cancer drug & Oncology medicines. We even supply & export Sex Enhancement Drugs, Cardiac & Anti Diabetic Medicines. We are a registered wholesaler & exporter for pharmaceutical products licensed by our FDA and Drug Controller in India. Our license number are 20-B/MZ6-23015 & 21-B/ MZ6-23016.

+(91)-(22)-42643060

3scorp.india@gmail.com
Andheri East, Mumbai - 400099, India.

DISCLAIMER

All the pharmaceutical products we offer are prescription drugs and should be used/taken under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug. We are not an online pharmacy . We do not recommend any drug or give medical advice. We only express opinions and provide information. Whether a medication is right for you is a decision between you and the prescribing doctor. Kindly seek medical advice from a registered doctor 0r hospital/Institution before taking any of these medicines.

Monday - Saturday

10.00 - 19.00

+(91)-(22)-42643060

3scorp.india@gmail.com

Andheri East

Mumbai – 400099, India.

Avastin 400 MG 16 ML

Description

AVASTIN®, in combination with intravenous 5‑fluorouracil‑based chemotherapy, is indicated for first- or second‑line treatment of patients with metastatic carcinoma of the colon or rectum. Avastin, in combination with carboplatin and paclitaxel, is indicated for first‑line treatment of patients with unresectable, locally advanced, recurrent or metastatic non-squamous, non-small cell lung cancer.

As of now, its is not available in India. Only Avastin 100 mg is available.

 

Manufacturer: Roche

Additional Information

DOSAGE AND ADMINISTRATION:

Do not initiate AVASTIN until at least 28 days following major surgery. The surgical incision should be fully healed prior to initiation of AVASTIN.

1. Metastatic Carcinoma of the Colon or Rectum

AVASTIN, used in combination with intravenous 5‑FU‑based chemotherapy, is administered as an intravenous infusion (5 mg/kg or 10 mg/kg) every 14 days.

The recommended dose of AVASTIN, when used in combination with bolus‑IFL, is 5 mg/kg.

The recommended dose of AVASTIN, when used in combination with FOLFOX4, is 10 mg/kg.

2. Non‑Squamous, Non‑Small Cell Lung Cancer

The recommended dose of AVASTIN is 15 mg/kg, as an IV infusion every 3 weeks.

Side Effects

Pack Size